Reprogramming of mouse and human somatic cells can be achieved by ectopic expression of transcription factors, but with low efficiencies. We report that DNA methyltransferase and histone deacetylase (HDAC) inhibitors improve reprogramming efficiency. In particular, valproic acid (VPA), an HDAC inhibitor, improves reprogramming efficiency by more than 100-fold, using Oct4-GFP as a reporter. VPA also enables efficient induction of pluripotent stem cells without introduction of the oncogene c-Myc.
Stem cells specific to an individual may be created by reprogramming somatic cells to a pluripotent state. Recently, pioneering work showed that forced expression of just four transcription factors, Oct4, Klf4, Sox2 and c-Myc, reprograms mouse embryonic fibroblasts (MEFs) into induced pluripotent stem (iPS) cells that closely resemble embryonic stem (ES) cells [1] [2] [3] [4] . Reprogramming human somatic cells has now been achieved through similar means [5] [6] [7] [8] [9] , suggesting that the mechanism of reprogramming is conserved between humans and mice. However, reprogramming by viral infection is a slow and inefficient process. In addition, genetic transformation with exogenous genes, in particular oncogenes such as c-Myc and Klf4, and the use of viral delivery systems handicap this method with regard to human therapeutic applications.
Previous studies have shown that histone deacetylase (HDAC) inhibitors and DNA demethylation have a modest effect (two-to fivefold) on the efficiency of reprogramming mediated by somatic cell nuclear transfer (SCNT) [10] [11] [12] . We speculated that reprogramming by defined factors may share common mechanisms with SCNT. Using an Oct4-GFP transgenic reporter 13 , we tested whether small molecules involved in chromatin modification have any effect on reprogramming ( Supplementary Fig. 1 online) . Retroviral expression of four transcription factors, Oct4, Sox2, Klf4 and c-Myc, in MEFs hemizygous for the Oct4-GFP transgene (Oct4-GFP /+ ) induced 0.03% ± 0.02% Supplementary Fig. 3a online). Dexamethasone (1 mM), a synthetic glucocorticoid, improved the effect of 5¢-azaC by 2.6-fold when used in combination, although dexamethasone alone had no significant effect. Three known HDAC inhibitors, suberoylanilide hydroxamic acid (SAHA), trichostatin A (TSA) and VPA also greatly improved reprogramming efficiency. VPA was the most potent of the three. Treating four factor-infected MEFs with 2 mM VPA for 1 week induced B11.8% ± 2.2% GFP + cells, which amounts to 4100-fold improvement over the control (Fig. 1a,b) . This reprogramming efficiency approached the estimated 13-41% viral co-transduction rate, arguing that most if not all cells infected with all four factors can be reprogrammed. VPA promoted reprogramming efficiency in a dose-dependent manner, with an EC 50 of B1.9 mM ( Supplementary  Fig. 3b ). The effect of VPA is much stronger than that of 5¢-azaC and other HDAC inhibitors tested. This could be due to toxicity of other chemicals at higher dosages. Alternatively, VPA may have additional activities, beyond inhibition of HDACs. Chemical treatment induced GFP + iPS colonies in greater numbers, consistent with the fluorescence-activated cell sorting (FACS) data. Eight days post-infection, an average of 10 and 241 colonies were observed in 5¢-azaC-and VPA-treated MEF cultures (out of 270,000 cells seeded), respectively. No GFP + colonies were observed 8 d postinfection without chemical treatment, though some did emerge after 10 d post-infection in untreated cells. The dramatic difference in colony numbers was maintained as more GFP + iPS colonies emerged in both the chemical-treated and nontreated MEF cultures during the following days; more than 8-and 40-fold increases in colony number were observed with 5¢-azaC and VPA treatment at 2 weeks postinfection, respectively.
In addition to improving the efficiency of reprogramming four factor-infected MEFs, chemical treatment allowed efficient induction of iPS cells without the oncogene c-Myc, which may be tumorigenic in cells derived from iPS cells 2 . Although reprogramming is possible with three factors (Oct4, Sox2 and Klf4) without c-Myc, the efficiency is extremely low and the appearance of iPS colonies significantly delayed compared to reprogramming with four factors. A previous study found that o1 iPS colony was formed from 100,000 human dermal fibroblasts infected (o0.001%) 7 , an efficiency that can make it difficult to derive individual-specific iPS cells from a small starting population of cells. Similar low efficiency was also reported for induction of iPS cells from mouse fibroblasts without c-Myc 14 . We tested whether treating the cells with 5¢-azaC or VPA could improve the efficiency of iPS colony formation without the need for c-Myc. Oct4-GFP /+ MEFs were first infected with Oct4, Sox2 and Klf4, and then treated with 5¢-azaC or VPA for 1 week starting 1 d postinfection. FACS analysis 10 d post-infection showed that treatment with 5¢-azaC increased reprogramming efficiency threefold, a small improvement (Fig. 1c) . Treatment with VPA improved reprogramming efficiency by 50-fold (Fig. 1c) . Notably, this reprogramming efficiency is superior to that achieved when MEFs were infected with all four factors without VPA treatment. Consistent with the FACS data, a 30-to 40-fold increase of GFP + colonies was observed compared to control-infected MEFs without treatment (Fig. 1d) . This allowed for picking of iPS colonies within 2 weeks post-infection, sooner than the typical B30 d post-infection or later without chemical treatment 7, 14 .
To examine whether VPA treatment changes the type of iPS cell generated, we established multiple iPS cell lines from three factorinfected MEFs. These iPS cells closely resembled mouse ES cells. They had typical ES cell morphology, stained for alkaline phosphatase and expressed pluripotent marker genes (Fig. 2a,b and Supplementary  Fig. 4 online). They were readily cultured without further chemical treatment and passaged more than ten times while maintaining ES cell morphology. Global gene expression profiling of iPS cells, MEFs and mouse ES cells showed that iPS cells induced with VPA treatment are distinct from MEFs and most similar to mouse ES cells (Fig. 2c) . The r 2 value (square of linear correlation coefficient) between iPS cells and mouse ES cells was 0.94-0.97 (Supplementary Table 1 online), similar to previous reports 3 . In contrast, the r 2 value between iPS cells (or mouse ES cells) and MEFs was only 0.62-0.66. Like ES cells, iPS cells induced by the three factors with VPA treatment developed teratomas in 3-5 weeks and differentiated into tissues representing all three germ layers (Fig. 2d) .
To further evaluate the pluripotency of the iPS cells induced by VPA treatment, we derived MEFs from mouse embryos carrying both the Oct4-GFP transgenic allele and the Rosa26-lacZ knock-in allele. iPS cell lines were derived from these MEFs infected with Oct4, Sox2 and Klf4. b-galactosidase staining showed that chimeras with a high contribution of iPS cell derivatives were obtained from all four iPS cell lines tested, with extensive contribution of the iPS cell derivatives to all three germ layers (Fig. 2e,f) . A number of chimeras developed into healthy adults. Germline transmission was confirmed by positive staining of b-galactosidase activity in embryos from matings between chimeric males and wild-type females (Fig. 2g) . Therefore, the iPS cells induced with VPA treatment fulfilled stringent criteria for pluripotency and closely resembled ES cells in all aspects examined.
The dramatic effect of VPA suggests that it may control a ratelimiting step in reprogramming. VPA treatment of uninfected MEFs does not induce Oct4-GFP + cells, indicating that VPA treatment alone is insufficient to reprogram MEFs. Nor does VPA treatment cause genetic changes when examined at the level of chromosomal abnormalities (Supplementary Table 2 online). Microarray analysis of uninfected MEFs treated with VPA for 1 week showed that this treatment induced a transcriptional program that can be described as leaning toward an ES-like pattern. Among 968 genes (out of 18,918 total genes) that are upregulated by more than tenfold in ES cells, compared to untreated MEFs, 66% are upregulated by more than twofold in VPA-treated MEFs. Only 4.5% of these genes are downregulated by more than twofold (Fig. 3) . For example, Rex3 and Zfp7, two genes expressed in undifferentiated ES cells, but not in untreated MEFs, are upregulated by more than 20-fold in MEFs treated with VPA (Supplementary Fig. 5 online) . Likewise, among the 214 genes downregulated by more than tenfold in ES cells compared to untreated MEFs, 55% are downregulated by more than twofold in VPA-treated MEFs, whereas only 6.2% were upregulated by more than twofold (Fig. 3) . For example, Aspn and Meox2, two genes expressed in MEFs but not in ES cells, were both downregulated by more than 20-fold in VPAtreated MEFs (Supplementary Fig. 5) . Therefore, the effect of VPA on reprogramming may be due to the collective effects of upregulation of ES-specific genes and downregulation of MEF-specific genes.
Our findings provide proof of principle that chemicals can increase reprogramming efficiency and may be used to replace one or more factors used for reprogramming. The demonstration that both DNA methyltransferase and HDAC inhibitors improve reprogramming efficiency suggests that chromatin modification is a key step in reprogramming fibroblasts to pluripotent cells. Given that the reprogramming factors are conserved between humans and mice [1] [2] [3] [4] [5] [7] [8] [9] 14 , these findings will likely apply to human cells. This encourages one to explore high-throughput screening of small-molecule libraries to achieve reprogramming through pure chemical means, making therapeutic use of reprogrammed cells safer and more practical.
Note: Supplementary information is available on the Nature Biotechnology website. Genes that were specifically expressed in ES cells and MEFs (more than tenfold difference) were selected, and scatter plots were generated to visualize the effect of VPA treatment on the expression of these genes.
Red lines indicate the linear equivalent and twofold changes in gene expression levels.
